Collaboration - May 25, 2022
Qlucore adds another cancer diagnostics area
The company has announced a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in the area of solid tumours. Cooperate with Lund University Combining Qlucore’s expertise in bioinformatic software and cancer diagnostics from Lund […]
Agreement - November 23, 2021
Boehringer Ingelheim signs license deal with Qlucore
Boehringer Ingelheim has ordered licenses from Qlucore at a value of approximately 142,000 EUR for the use of Qlucore Omics Explorer for two years. Boehringer Ingelheim is an existing Qlucore customer, and this license is for global use of Qlucore’s software. Qlucore Omics Explorer is software for research applications within the pharma, biotech and academic […]
Listing - November 11, 2021
Qlucore approved for listing on Nasdaq First North Growth Market
Qlucore has received approval of the application for listing of Qlucore shares on the Nasdaq First North Growth Market. The first day of trading of the shares was 5th November 2021. Trading will be done with the ticker QCORE. “This paves the way for a new phase in Qlucore’s development. With the funding from the […]
